|
Wednesday, October 6, 2010 | 8:30 AM - 7:00 PM | Recently uncovered genetics defects predispose to Parkinson’s disease and new animal models better mimic human disease. This upcoming conference will examine recent advances in the understanding and treatment of this neurodegenerative disorder. More
Challenges in developing a vaccine against HIV/AIDS infection include genetic diversity of the virus and predictive models of infection. This symposium tackled each challenge in turn, and covered other mechanisms to reduce HIV transmission. More
Proceedings of the “Ninth Cooley's Anemia Symposium,” held at the New York Academy of Sciences. More
-
Tuesday, September 21, 2010 | 6:30 PM - 8:00 PM
Speaker: Christiane Northrup (Christiane Northrup, Inc.)
A leading proponent of medicine and healing that acknowledges the unity of the mind and body discusses the vital connection between pleasure and health.
Tuesday, September 28, 2010 | 1:00 PM - 5:00 PM
Speakers: Fadi G. Akar (Mount Sinai School of Medicine), Roger J. Hajjar (Mount Sinai School of Medicine), Mariell Jessup (University of Pennsylvania College of Medicine), Walter J. Koch (Thomas Jefferson University), and Evangelia Kranias (University of Cincinnati College of Medicine)
Development of therapies to treat heart failure is hampered by a lack of understanding of underlying mechanisms. This symposium reviews current and potential therapeutic approaches, and research to identify useful molecular targets.
Wednesday, October 6, 2010 | 8:30 AM - 7:00 PM
Chair: Franz Hefti, PhD (Avid Radiopharmaceuticals)
This conference will highlight novel and innovative therapeutic targets for Parkinson’s Disease, biomarkers for early detection and assessment of disease progression, and emerging strategies to alleviate symptoms and/or to slow disease progression.
Tuesday, October 26, 2010 | 1:00 PM - 5:00 PM
Speakers: Katerina Akassoglou (Gladstone Institute & UCSF), Andrew Miller (Emory University School of Medicine), Malú Tansey (Emory University School of Medicine), Shi Du Yan (Columbia University) and Raz Yirmiya (Hebrew University)
Breakthroughs spanning neuroscience and immunology are rare, as they do not share a common language or purpose. This symposium highlights recent discoveries in clinical depression, the stress response, Alzheimer's and multiple sclerosis.
Tuesday, November 16, 2010 | 1:00 PM - 5:00 PM
Speakers: Greg Hannon (Cold Spring Harbor Laboratory), Pier Paolo Pandolfi (Harvard Medical School), John Rinn (Harvard Medical School), Ramin Shiekhattar (The Wistar Institute), David Spector (Cold Spring Harbor Laboratory)
Non- coding RNAs are emerging as important regulators of development and function in many physiological processes. Their role in controlling pathogenesis and their potential as targets for therapeutic intervention are becoming increasingly apparent.
Wednesday, June 23, 2010 | 8:15 AM - 5:30 PM
Despite vast advances in biomedical research and technology, the medical school curriculum has remained mostly static for the past half century. This goal of this conference is to highlight innovative new models for physician training motivated by advances in science and technology, and to consider how to more closely link basic science and clinical training.
Wednesday, May 19, 2010 | 9:00 AM - 5:30 PM
Organizers: Sarah Schlesinger (The Rockefeller University), Yegor Voronin (Global HIV Vaccine Enterprise) and Jennifer Henry (The New York Academy of Sciences)
Challenges in developing a vaccine against HIV / AIDS infection include genetic diversity of the virus, and predictive models of infection. This symposium tackles each challenge in turn, and covers other mechanisms to reduce HIV transmission.
May 19 - 21, 2010 | Spain
Keynote Speaker: J. Michael Bishop (The G.W. Hooper Research Foundation, University of California, San Francisco)
This conference will discuss advancements, challenges, and future steps in research leading to an individualized understanding of cancer and its translation into personalized clinical care.
May 14 - 15, 2010
Organizers: Ali K. Abu-Alfa (Yale Medical School) and Shawn Cowper (Yale Medical School)
Join expert scientists and physicians in nephrology, radiology, rheumatology, dermatology and pathology for a CME accredited meeting to discuss this rare disease.
|
-
Annals
Edited by George Creatsas and George Mastorakos (University of Athens Medical School, Athens, Greece)
This volume includes manuscripts from the "The 7th Athens Congress on Women's Health and Disease," which was held in Athens, Greece on September 11-13, 2008.
Forthcoming issue
Annals
Edited by Elliott Vichinsky (Children's Hospital and Research Center, Oakland, California) and Ellis Neufeld (Harvard Medical School, Children's Hospital, Boston, Massachusetts)
Proceedings of the “Ninth Cooley's Anemia Symposium,” held at the New York Academy of Sciences.
eBriefing
Organizers: Sarah Schlesinger (The Rockefeller University), Yegor Voronin (Global HIV Vaccine Enterprise), and Jennifer Henry (The New York Academy of Sciences)
Challenges in developing a vaccine against HIV/AIDS infection include genetic diversity of the virus and predictive models of infection. This symposium tackled each challenge in turn, and covered other mechanisms to reduce HIV transmission.
Annals
Robert B. Nussenblatt (Laboratory of Immunology, National Eye Institute), Bibiana Bielekova (Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke), Richard Childs (Hematology Branch, National Heart, Lung, and Blood Institute), Alan Krensky (Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute), Warren Strober (Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases), and Giorgio Trinchieri (Cancer Imaging Program, National Cancer Institute), for the Center for Human Immunology, Autoimmunity and Inflammation, National Institutes of Health, Bethesda, Maryland Free online access
This meeting report presents the National Institutes of Heath -- National Heart, Lung, and Blood Institute's Center for Human Immunology (CHI) first "Meeting the Human Immunology Challenge" Symposium, held September 3-4, 2009.
eBriefing
Organizers: Ildiko Antal (Bristol-Myers Squibb), Chad E. Beyer (University of Colorado School of Medicine), Mark R. Bowlby (Merck Research Laboratories), Beth Winkelstein (University of Pennsylvania), and Jennifer Henry (The New York Academy of Sciences)
This symposium addressed clinical applications and new pain mechanisms for the treatment of chronic pain syndromes, and provided an update on the progress and barriers to developing effective preclinical models of pain, in particular fibromyalgia.
|
|
|